Comparison between Neochem Bio IPO and ScaleSauce IPO.
Neochem Bio IPO is a SME Bookbuilding IPO proposed to list at NSE SME while ScaleSauce IPO is a SME Bookbuilding proposed to list at NSE SME.
| Neochem Bio IPO | ScaleSauce IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Vivro Financial Services Pvt.Ltd. | 3Dimension Capital Services Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | ||
| DRHP | DRHP  | DRHP |
| RHP | ||
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Neochem Bio IPO is up to ₹0.00 Cr whereas the issue size of the ScaleSauce IPO is up to ₹0.00 Cr. The final issue price of Neochem Bio IPO is and of ScaleSauce IPO is .
| Neochem Bio IPO | ScaleSauce IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 47,50,000 shares | 37,58,400 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 47,50,000 shares | 37,58,400 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Neochem Bio IPO opens on , while ScaleSauce IPO opens on . The closing date of Neochem Bio IPO and ScaleSauce IPO is , and , respectively.
| Neochem Bio IPO | ScaleSauce IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | ||
| Issue Close | ||
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Neochem Bio IPO P/E ratio is , as compared to ScaleSauce IPO P/E ratio of .
| Neochem Bio IPO | ScaleSauce IPO | |||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | EBITDA | Encompass Design India Ltd. Financial Information (Restated Consolidated)Encompass Design India Ltd.'s revenue increased by 37% and profit after tax (PAT) rose by 58% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 91.12 | 80.19 | ||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||
| ROE | 48.82% | 50.26% | ||||||||||||||||||||||||||||||||
| ROCE | 41.67% | 40.49% | ||||||||||||||||||||||||||||||||
| Debt/Equity | 1.80 | 0.44 | ||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||
| RoNW | 48.82% | 33.13% | ||||||||||||||||||||||||||||||||
In the Neochem Bio IPO Retail Individual Investors (RII) are offered 0 shares while in ScaleSauce IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Neochem Bio IPO and 0 shares in ScaleSauce IPO.
| Neochem Bio IPO | ScaleSauce IPO | |
|---|---|---|
| Anchor Investor Reserveration | 0 shares | 0 shares |
| Market Maker Reserveration | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Neochem Bio IPO subscribed in total, whereas ScaleSauce IPO subscribed .
| Neochem Bio IPO | ScaleSauce IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
